Kezar Life Sciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:KZR Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
08 Oct 24	BuyUS$6,048,000	Kevin Tang	Individual		720,000	US$8.40
02 Jul 24	SellUS$3,879	Mark Schiller	Individual		668.8	US$5.80

Insider Trading Volume

Insider Buying: KZR insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of KZR?
Owner Type	Number of Shares	Ownership Percentage
VC/PE Firms	625,455	8.57%
Individual Insiders	907,352	12.4%
Hedge Funds	1,219,359	16.7%
General Public	1,628,033	22.3%
Institutions	2,916,023	40%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 73.66% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.87%	Kevin Tang	720,000	US$4.9m	0%	no data
9.82%	Suvretta Capital Management, LLC	716,759	US$4.9m	0%	0.17%
8.57%	Equal Talent Investments Ltd	625,455	US$4.3m	0%	100.0%
6.89%	Avidity Partners Management, L.P.	502,600	US$3.4m	0%	0.19%
5.25%	Barclays Bank PLC, Wealth and Investment Management Division	382,736	US$2.6m	0%	0.02%
3.76%	The Vanguard Group, Inc.	274,110	US$1.9m	0%	no data
3.44%	Affinity Asset Advisors, LLC	251,177	US$1.7m	42.6%	0.29%
2.67%	The Morningside Group Limited	194,799	US$1.3m	0%	0.24%
2.64%	OrbiMed Advisors LLC	192,700	US$1.3m	0%	0.02%
2.16%	Acadian Asset Management LLC	157,712	US$1.1m	-15%	no data
2.04%	Stonepine Capital Management LLC	149,130	US$1.0m	42%	0.35%
1.92%	Two Sigma Advisers, LP	140,290	US$956.8k	13.4%	no data
1.83%	ADAR1 Capital Management, LLC	133,827	US$912.7k	23.2%	0.17%
1.78%	Renaissance Technologies LLC	129,707	US$884.6k	66.6%	no data
1.68%	Acuitas Investments, LLC	122,752	US$837.2k	24.4%	0.24%
1.47%	Ikarian Capital, LLC	106,899	US$729.1k	23%	0.21%
1.24%	Two Sigma Investments, LP	90,176	US$615.0k	-21.5%	no data
1.22%	Franklin Berger	89,069	US$607.5k	0%	no data
1.14%	Qiming Weichuang Venture Capital Management (Shanghai) Company Limited	82,871	US$565.2k	0%	0.05%
1.14%	BlackRock, Inc.	82,857	US$565.1k	-0.22%	no data
0.86%	Geode Capital Management, LLC	62,691	US$427.6k	15%	no data
0.68%	Millennium Management LLC	49,422	US$337.1k	-21.4%	no data
0.6%	John Fowler	43,612	US$297.4k	0%	no data
0.59%	Christopher Kirk	43,135	US$294.2k	0%	no data
0.41%	Goldman Sachs Group, Investment Banking and Securities Investments	29,777	US$203.1k	-69.4%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/31 12:33
End of Day Share Price	2024/12/31 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kezar Life Sciences, Inc. is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Raghuram Selvaraju	H.C. Wainwright & Co.
Maurice Raycroft	Jefferies LLC
Catherine Novack	JonesTrading Institutional Services, LLC